The Latest News
It’s a conundrum for vaccine researchers and producers alike: what’s the best strategy for vaccinating against a deadly virus if the immune system will forget how to protect itself against it a year later? Recent research that suggests that novel coronavirus immunity doesn’t last very long have thrown a wrench in the global plans to develop…
The former pharmaceutical executive tapped by President Donald Trump to lead the administration’s race to a COVID-19 vaccine is refusing to give up investments that stand to benefit from his work — at least during his lifetime. The executive, Moncef Slaoui, is the top scientist on Operation Warp Speed, the administration’s effort to develop a…
Skip to main content HomeCoronavirus Updates2020 Election ResultsElectionsNationWorldPoliticsFactcheckEducationInvestigationsHealthWeatherRace in AmericaImpeachmentJust the FAQsTracking 2020Register to VoteVoter GuideAn international study of a COVID-19 vaccine that aims to work with just one dose is getting underway as top U.S. health officials sought Wednesday to assure a skeptical Congress and public that they can trust any shots the government…
Americans are desperate to know when a coronavirus vaccine will be available to finally curb the pandemic that has already taken nearly 200,000 lives in the United States, and allow schools and the broader economy to reopen. Scientists and vaccine makers have long said that a handful of vaccines could be available by the end…
The president on Wednesday claimed that a coronavirus vaccine could be ready for distribution as early as mid-October, a claim he issued hours after the head of the CDC, Dr. Robert Redfield, testified it likely wouldn’t be ready until spring or summer of 2021.Sept. 17, 2020
Need help? Contact us We’ve detected unusual activity from your computer network To continue, please click the box below to let us know you’re not a robot. Why did this happen? Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review…
The U.S. should have enough Covid-19 vaccine doses for Americans to return to “regular life” by the third quarter of next year, the head of the Centers for Disease Control and Prevention said Wednesday.CDC Director Dr. Robert Redfield told a Senate panel he expects vaccinations to begin in November or December, but in limited quantities with those…
Need help? Contact us We’ve detected unusual activity from your computer network To continue, please click the box below to let us know you’re not a robot. Why did this happen? Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review…
Trust us — Trump denied politicizing vaccine but said it could arrive “before a very special date.” Beth Mole – Sep 8, 2020 10:06 pm UTC Enlarge / Woman receives an experimental COVID-19 vaccine at the University of Massachusetts Medical School in Worcester, MA on September 04, 2020, as part of a clinical trial.In an…
© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Info | Ad Choices FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE…
From Russia with adenovirus — Most of the results are fairly expected, but there are some interesting details. John Timmer – Sep 5, 2020 8:14 pm UTC Enlarge / MOSCOW, RUSSIA – SEPTEMBER 4, 2020: Medical staff with newly delivered boxes containing COVID-19 vaccine in a cold room at No2 Outpatient Clinic in southern Moscow.…
© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Info | Ad Choices FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE…